Editorial: Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders

Front Psychiatry. 2023 May 12:14:1191970. doi: 10.3389/fpsyt.2023.1191970. eCollection 2023.

Authors

Grace Blest-Hopley¹, Ben H Amit², Aisling O'Neill^{3

4}, Simon G D Ruffell^{4

5

6}

Affiliations

¹ King's College London, London, United Kingdom.
² Tel Aviv Medical Center, Tel Aviv, Israel.
³ Department of Psychology, University College Dublin, Dublin, Ireland.
⁴ Department of Psychology, St Patrick's Mental Health Services, Dublin, Ireland.
⁵ Onaya Science, Iquitos, Peru.
⁶ Psychae Institute, Melbourne, VIC, Australia.

No abstract available

Keywords: cannabinoids; cannabis; hallucinogenic; psilocybin; psychedelics.

Publication types

Editorial